Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation

Molecular Nutrition and Food Research

Volumn 52, Issue 7, 2008, Pages 815-822

  Fridrich, Diana ^a   Teller, Nicole ^a   Esselen, Melanie ^a   Pahlke, Gudrun ^a   Marko, Doris ^a  

^a UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

A431; Autophosphorylation; Cellular signalling; ERK; HT29

Indexed keywords

ANTHOCYANIN; CATECHIN; DELPHINIDIN; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIGALLOCATECHIN GALLATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; QUERCETIN;

ARTICLE; CARCINOMA; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; TUMOR CELL LINE; VULVA TUMOR;

ANTHOCYANINS; CARCINOMA; CATECHIN; CELL LINE, TUMOR; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; QUERCETIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; VULVAR NEOPLASMS;

EID: 53249119839     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800026     Document Type: Article

References (33)

1. Verriah, S., Kautenburger, T., Habermann, S., Sauer, J., et al., Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobiotics. Mol. Carcinog. 2006, 45, 164-174.
2. Nguyen, T. T., Tran, E., Nguyen, T. H., Do, P. T., et al., The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004, 25, 647-659.
3. Karnes, W. E. Jr., Weller, S. G., Adjei, P. N., Kottke, T. J., et al., Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells. Gastroenterology 1998, 114, 930-939.
4. Liang, Y. C., Lin-Shiau, S. Y., Chen, C. F., Lin, J. K., Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell Biochem. 1997, 67, 55-65.
5. Meiers, S., Kemény, M., Weyand, U., Gastpar, R., et al., The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth factor receptor. J. Agric. Food Chem. 2004, 49, 958-962.
6. Marko, D., Puppel, N., Tjaden, Z., Jakobs, S., Pahlke, G., The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation. Mol. Nutr. Food Res. 2004, 48, 318-325.
7. Kern, M., Tjaden, Z., Ngiewih, Y., Puppel, N., et al., Inhibitors of the epidermal growth factor receptor in apple juice extract, Mol. Nutr. Food Res. 2005, 49, 317-328.
8. van der Geer, P., Hunter, T., Lindberg, R. A., Receptor protein tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol. 1994, 10, 251-337.
9. Yarden, Y., Sliwkowski, M. X., Untangling the ErbB signalling network, Nat. Rev. Mol. Cell. Biol. 2001, 2, 127-137.
10. Rubin, I., Yarden, Y., The basic biology of HER2, Ann. Oncol. 2001, 12, 3-8.
11. Bazely, L. A., Gullick, W. J., The epidermal growth factor receptor family, Endocr. Relat. Canc. 2005, 12, 17-27.
12. Olayioye, M. A., Neve, R. M., Lane, H. A., Hynes, N. E., The ErbB signalling network: Receptor heterodimerization in development and cancer. EMBO J. 2000, 19, 3159-3167.
13. Prenzel, N., Fischer, O. M., Streit, S., Hart, S., Ullrich, A., The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Canc. 2001, 8, 11-31.
14. Wells, A., Molecules in focus: EGF receptor. Int. J. Biochem. Cell Biol. 1999, 31, 637-643.
15. Pinkas-Kramarski, R., Shelly, M., Guarino, B. C., Wang, L. M., et al., ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol. Cell Biol. 1998, 18, 6090-6101.
16. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P. J., et al., Epidermal growth factor receptor: mechanisms of activation and signaling. Exp. Cell Res. 2003, 284, 31-53.
17. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., et al., Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 1996, 15, 2452-2467.
18. Burden, S., Yarden, Y., Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis. Neuron 1997, 18, 847-855.
19. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., et al., A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell Biol. 1996, 16, 5276-5287.
20. Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., et al., ErbB-2 is a common auxilary subunit of NDFand EGF receptors: Implications for breast cancer. EMBO J. 1996, 15, 254-264.
21. Sah, J. F., Balasubramanian, S., Eckert, R. L., Rorke, E. A., Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signalling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 2004, 279, 12755-12762.
22. Fridrich, D., Kern, M., Fritz, J., Pahlke, G., et al., The epidermal growth factor receptor and human topoisomerases represent potential cellular targets of oligomeric procyanidins. Mol. Nutr. Food Res. 2007, 51, 192-200.
23. Lee, L. T., Huang, Y. T., Hwang, J. J., Lee, P. P., et al., Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res. 2002, 22, 1615-1627.
24. Bhatia, N., Agarwal, C., Agarwal, R., Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Nutr. Canc. 2001, 39, 292-299.
25. Zhou, Y., Brattain, M. G., Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and Erb2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis, Canc. Res., 2005, 65, 5848-5856.
26. Fritz, J., Kern, M., Pahlke, G., Vatter, S., Marko, D., Biological activities of malvidin, a red wine anthocyanidin, Mol. Nutr. Food Res. 2006, 50, 390-395.
27. Shimizu, M., Deguchi, A., Hara, Y., Moriwaki, H., Weinstein, I. B., EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 2005, 334, 947-953.
28. Matsumoto, H., Ichiyanagi, T., Iida, H., Ito, K., et al., Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats. J Agric Food Chem. 2006, 54, 578-582.
29. Manach, C., Williamson, G., Morand, C., Scalbert, A., Rémésy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230-242.
30. Russell, W. R., Labalt, A., Scobbie, L., Duncan, S. H., Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol. Nutr. Food Res. 2007, 51, 726-731.
31. Wu, X., Pittman, H. E., Prior, R. L., Fate of anthocyanins and antioxidant capacity in contents of the gastrointestinal tract of weanling pigs following black raspberry consumption. J. Agric. Food Chem. 2006, 54, 583-589.
32. Kahle, K., Kraus, M., Scheppach, W., Ackermann, M., et al., Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon? Mol. Nutr. Food Res. 2006, 50, 418-423.
33. Lambert, J. D., Yang, C. S., Mechanisms of cancer prevention by tea constituents. J. Nutr. 2003, 10, 3262-3267.